(Q54228292)

English

Divergent in vivo and in vitro antileukemic activity of recombinant interferon beta in patients with chronic-phase chronic myelogenous leukemia.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/7694661

Divergent in vivo and in vitro antileukemic activity of recombinant interferon beta in patients with chronic-phase chronic myelogenous leukemia. (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/7694661

chronic phase chronic myelogenous leukemia

0 references

author name string

W E Aulitzky

1

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/7694661

C Peschel

2

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/7694661

D Desprès

3

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/7694661

J Aman

4

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/7694661

P Trautman

5

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/7694661

H Tilg

6

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/7694661

G Rudolf

7

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/7694661

H Hüttmann

8

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/7694661

J Obermeier

9

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/7694661

M Herold

10

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/7694661

publication date

1 November 1993

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/7694661

Annals of Hematology

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/7694661

67

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/7694661

5

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/7694661

205-211

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/7694661

Interferon: pharmacokinetics and toxicity

1 reference

https://api.crossref.org/works/10.1007%2FBF01715048

21 January 2018

Intrathecally administered natural human fibroblast interferon reduces exacerbations of multiple sclerosis. Results of a multicenter, double-blind study

1 reference

https://api.crossref.org/works/10.1007%2FBF01715048

21 January 2018

A micro agar culture system for cloning human erythropoietic progenitors in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/7694661

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suppression of chronic myelogenous leukemia colony growth by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors: a novel application for inhibitors of IL-1 activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/7694661

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha A in chronic myelogenous leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/7694661

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multicentre double-blind study of effect of intrathecally administered natural human fibroblast interferon on exacerbations of multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/7694661

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Central nervous system toxicity of interferons and other cytokines

1 reference

https://pubmed.ncbi.nlm.nih.gov/7694661

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon levels in human pulmonary tumors are lower than plasma levels

1 reference

https://pubmed.ncbi.nlm.nih.gov/7694661

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical investigation of human alpha interferon in chronic myelogenous leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7694661

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of circulating IL-1 receptor antagonist by IFN treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/7694661

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human biologic response modification by interferon in the absence of measurable serum concentrations: a comparative trial of subcutaneous and intravenous interferon-beta serine

1 reference

https://pubmed.ncbi.nlm.nih.gov/7694661

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical toxicity of interferons in cancer patients: a review

1 reference

https://pubmed.ncbi.nlm.nih.gov/7694661

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Myelopoiesis of human bone marrow cells in a micro-agar culture system: comparison of two sources of colony stimulating activity (CSA)

1 reference

https://pubmed.ncbi.nlm.nih.gov/7694661

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Leukocyte interferon-induced myeloid cytoreduction in chronic myelogenous leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/7694661

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravenous recombinant interferon beta in patients with recurrent malignant gliomas: a phase I/II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/7694661

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant beta-serine-interferon in hairy cell leukemia compared prospectively with results with recombinant alpha-interferon

1 reference

https://pubmed.ncbi.nlm.nih.gov/7694661

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant interferon alpha-2c in Ph-positive chronic myeloid leukemia. Results of a multicenter phase II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/7694661

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon-alpha produces sustained cytogenetic responses in chronic myelogenous leukemia. Philadelphia chromosome-positive patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/7694661

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytokines in the control of beta-2 microglobulin release. I. In vitro studies on various haemopoietic cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/7694661

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon (IFN) therapy (recombinant IFN-alpha-2C or recombinant IFN-gamma) in metastasized hypernephroma

1 reference

https://pubmed.ncbi.nlm.nih.gov/7694661

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proposal for a simple synthesis prognostic staging system in chronic myelogenous leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/7694661

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biotherapy of chronic myelogenous leukemia with interferon

1 reference

https://pubmed.ncbi.nlm.nih.gov/7694661

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I/II trial of human recombinant beta-interferon serine in patients with renal cell carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7694661

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Formation of neutralizing antibodies against natural interferon-beta, but not against recombinant interferon-gamma during adjuvant therapy for high-risk malignant melanoma patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/7694661

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial of natural human interferon beta in metastatic malignancy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7694661

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alteration in bone marrow adherent layer growth factor expression: a novel mechanism of chronic myelogenous leukemia progression

1 reference

https://pubmed.ncbi.nlm.nih.gov/7694661

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Constitutive and induced expression of growth factors in normal and chronic phase chronic myelogenous leukemia Ph1 bone marrow stroma

1 reference

https://pubmed.ncbi.nlm.nih.gov/7694661

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant human interferon (IFN) alpha-2b in chronic myelogenous leukaemia: dose dependency of response and frequency of neutralizing anti-interferon antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/7694661

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A biological approach to optimize interferon treatment in hairy cell leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/7694661

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant interferon beta: a phase I-II trial in children with recurrent brain tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/7694661

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon-beta induced remission in a hairy cell leukemia patient resistant to interferon-alpha

1 reference

https://pubmed.ncbi.nlm.nih.gov/7694661

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Beta interferon therapy in hairy cell leukemia]

1 reference

https://pubmed.ncbi.nlm.nih.gov/7694661

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF01715048

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/7694661

release_h3jmqn3inrcvrk3d6chrvk7wkq

1 reference

https://api.fatcat.wiki/v0/release/h3jmqn3inrcvrk3d6chrvk7wkq

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/7694661

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54228292&oldid=1836574289"